semaglutide and sleep apnea glp-1 approved for Did You Know? The FDA has approved GLP-1 treatments for moderate to severe obstructive sleep apnea (OSA) in adults with obesity. This breakthrough provides a new Survey: Providers Want GLP-1s Approved

EBioMedicine 48 , 130142 (2019)

Vehicle dosed animals on average fell after 291.9 15.1 s at 6 weeks of age and 195.4 71.8 s at 6 months of age and liraglutide dosed animals fell on average after 289.2 16.1 s at 6 weeks of age and 198.1 63.0 s at 6 months of age (Fig

Genetic study of early-onset Graves disease in the Chinese Han population

Clin Cancer Res 18:54385448 Hatano Y, Semi K, Hashimoto K, Lee MS, Hirata A, Tomita H et al (2015) Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation

A 2018 review identified several demonstrated capabilities of GHK-Cu: Research from 2015 noted that GHK-Cu may stimulate collagen production, regulate the skin remodeling process, attract immune cells to injury sites, and restore replicative vitality to fibroblasts (cells that help form connective tissue) in patients whove undergone radiation therapy for cancer

However, Gipr Syn/ mice had reduced total plasma cholesterol, regardless of treatment, compared to vehicle-treated Gipr fl/fl control mice (Extended Data Fig